1. Passarello K, Kurian S, Villanueva V. Endometrial Cancer: An Overview of Pathophysiology, Management, and Care. Semin Oncol Nurs. 2019;35:157–165. [PubMed] [Google Scholar]
2. Saboor Aftab SA, Kumar S, Barber TM. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin Endocrinol (Oxf) 2013;78:330–337. [PubMed] [Google Scholar]
3. Bobulescu IA, Lotan Y, Zhang J, Rosenthal TR, Rogers JT, Adams-Huet B, Sakhaee K, Moe OW. Triglycerides in the human kidney cortex: relationship with body size. PLoS One. 2014;9:e101285. [PMC free article] [PubMed] [Google Scholar]
4. Feldman M, Friedman LS, Sleisenger MH, Scharschmidt BF. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management electronic resource. Elsevier, 2016. [Google Scholar]
5. Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, Nguyen MH. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One. 2017;12:e0173499. [PMC free article] [PubMed] [Google Scholar]
6. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. NCHS Data Brief. 2017:1–8. [PubMed] [Google Scholar]
7. Schaefer JH. The normal weight of the pancreas in the adult human being: A biometric study. Anatomic Record. 1926;32:119–132. [Google Scholar]
8. Ogilvie RF. The islands of langerhans in 19 cases of obesity. J Pathol Bacteriol. 1933;37:473–481. [Google Scholar]
9. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A. 1978;86A:367–373. [PubMed] [Google Scholar]
10. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol. 1984;15:677–683. [PubMed] [Google Scholar]
11. Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169–177. [PubMed] [Google Scholar]
12. Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterology Res. 2016;9:87–91. [PMC free article] [PubMed] [Google Scholar]
13. Yu TY, Wang CY. Impact of non-alcoholic fatty pancreas disease on glucose metabolism. J Diabetes Investig. 2017;8:735–747. [PMC free article] [PubMed] [Google Scholar]
14. Weng S, Zhou J, Chen X, Sun Y, Mao Z, Chai K. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. Medicine (Baltimore) 2018;97:e11293. [PMC free article] [PubMed] [Google Scholar]
15. Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism. 2017;69:1–13. [PubMed] [Google Scholar]
16. Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterol. 2015;15:174. [PMC free article] [PubMed] [Google Scholar]
17. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol. 2013;12:77. [PMC free article] [PubMed] [Google Scholar]
18. Pezzilli R, Calculli L. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes. 2014;5:415–419. [PMC free article] [PubMed] [Google Scholar]
19. Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Saraswati R, Novelli M, Fusai G, Rappa F, Saracino C, Pazienza V, Poston L, Taylor PD, Vinciguerra M, Oben JA. Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. PLoS One. 2014;9:e89505. [PMC free article] [PubMed] [Google Scholar]
20. Soeda J, Mouralidarane A, Cordero P, Li J, Nguyen V, Carter R, Kapur SR, Pombo J, Poston L, Taylor PD, Vinciguerra M, Oben JA. Maternal obesity alters endoplasmic reticulum homeostasis in offspring pancreas. J Physiol Biochem. 2016;72:281–291. [PMC free article] [PubMed] [Google Scholar]
21. Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One. 2013;8:e62561. [PMC free article] [PubMed] [Google Scholar]
22. Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, Son BK, Jo YJ, Park YS, Kim YS. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15:1869–1875. [PMC free article] [PubMed] [Google Scholar]
23. Pham YH, Bingham BA, Bell CS, Greenfield SA, John SD, Robinson LH, Eissa MA. Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center. South Med J. 2016;109:196–198. [PubMed] [Google Scholar]
24. Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J, Woodward T, Noh K, Raimondo M. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas. 2009;38:672–675. [PubMed] [Google Scholar]
25. Uygun A, Kadayifci A, Demirci H, Saglam M, Sakin YS, Ozturk K, Polat Z, Karslioglu Y, Bolu E. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26:37–41. [PubMed] [Google Scholar]
26. Rosenblatt R, Mehta A, Snell D, Hissong E, Kierans AS, Kumar S. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis. Dig Dis Sci. 2019;64:262–268. [PubMed] [Google Scholar]
27. Wang CY, Ou HY, Chen MF, Chang TC, Chang CJ. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc. 2014;3:e000297. [PMC free article] [PubMed] [Google Scholar]
28. Kühn JP, Berthold F, Mayerle J, Völzke H, Reeder SB, Rathmann W, Lerch MM, Hosten N, Hegenscheid K, Meffert PJ. Pancreatic Steatosis Demonstrated at MR Imaging in the General Population: Clinical Relevance. Radiology. 2015;276:129–136. [PMC free article] [PubMed] [Google Scholar]
29. Wong VW, Wong GL, Yeung DK, Abrigo JM, Kong AP, Chan RS, Chim AM, Shen J, Ho CS, Woo J, Chu WC, Chan HL. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol. 2014;109:589–597. [PubMed] [Google Scholar]
30. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab. 2009;94:4070–4076. [PMC free article] [PubMed] [Google Scholar]
31. Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, Mehta G, Chuttani R, Kane R, Pleskow D, Sawhney MS. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc. 2011;73:987–993. [PubMed] [Google Scholar]
32. Hong CP, Yun CH, Lee GW, Park A, Kim YM, Jang MH. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders. Obesity (Silver Spring) 2015;23:2199–2206. [PubMed] [Google Scholar]
33. Wang C, Zhang M, Wu J, Li W, Ha X, Gu Y, Han B, Xie J, Zhang J. The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation. Mediators Inflamm. 2018;2018:6313484. [PMC free article] [PubMed] [Google Scholar]
34. Choi CW, Kim Y, Kim JE, Seo EY, Zouboulis CC, Kang JS, Youn SW, Chung JH. Enhancement of lipid content and inflammatory cytokine secretion in SZ95 sebocytes by palmitic acid suggests a potential link between free fatty acids and acne aggravation. Exp Dermatol. 2019;28:207–210. [PubMed] [Google Scholar]
35. Sun H, Sun Z, Varghese Z, Guo Y, Moorhead JF, Unwin RJ, Ruan XZ. Nonesterified free fatty acids enhance the inflammatory response in renal tubules by inducing extracellular ATP release. Am J Physiol Renal Physiol. 2020;319:F292–F303. [PubMed] [Google Scholar]
36. Sureda A, Martorell M, Bibiloni MDM, Bouzas C, Gallardo-Alfaro L, Mateos D, Capó X, Tur JA, Pons A. Effect of Free Fatty Acids on Inflammatory Gene Expression and Hydrogen Peroxide Production by Ex Vivo Blood Mononuclear Cells. Nutrients. 2020;12 [PMC free article] [PubMed] [Google Scholar]
37. Gotoh K, Inoue M, Shiraishi K, Masaki T, Chiba S, Mitsutomi K, Shimasaki T, Ando H, Fujiwara K, Katsuragi I, Kakuma T, Seike M, Sakata T, Yoshimatsu H. Spleen-derived interleukin-10 downregulates the severity of high-fat diet-induced non-alcoholic fatty pancreas disease. PLoS One. 2012;7:e53154. [PMC free article] [PubMed] [Google Scholar]
38. Nuñez-Durán E, Chanclón B, Sütt S, Real J, Marschall HU, Wernstedt Asterholm I, Cansby E, Mahlapuu M. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. J Endocrinol. 2017;234:15–27. [PMC free article] [PubMed] [Google Scholar]
39. López JM, Bombi JA, Valderrama R, Giménez A, Parés A, Caballería J, Imperial S, Navarro S. Effects of prolonged ethanol intake and malnutrition on rat pancreas. Gut. 1996;38:285–292. [PMC free article] [PubMed] [Google Scholar]
40. Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 2010;34:396–400. [PubMed] [Google Scholar]
41. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008;16:522–530. [PubMed] [Google Scholar]
42. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, Nakeeb A, Zyromski NJ, Lillemoe KD. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058–1064. [PubMed] [Google Scholar]
43. Matsumoto S, Mori H, Miyake H, Takaki H, Maeda T, Yamada Y, Oga M. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194:453–458. [PubMed] [Google Scholar]
44. Choi CW, Kim GH, Kang DH, Kim HW, Kim DU, Heo J, Song GA, Park DY, Kim S. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J Gastroenterol. 2010;16:4329–4334. [PMC free article] [PubMed] [Google Scholar]
45. Fujii M, Ohno Y, Yamada M, Kamada Y, Miyoshi E. Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup. Environ Health Prev Med. 2019;24:10. [PMC free article] [PubMed] [Google Scholar]
46. Hung CS, Tseng PH, Tu CH, Chen CC, Liao WC, Lee YC, Chiu HM, Lin HJ, Yang WS, Chen MF, Wu MS. Increased Pancreatic Echogenicity with US: Relationship to Glycemic Progression and Incident Diabetes. Radiology. 2018;287:853–863. [PubMed] [Google Scholar]
47. Worthen NJ, Beabeau D. Normal pancreatic echogenicity: relation to age and body fat. AJR Am J Roentgenol. 1982;139:1095–1098. [PubMed] [Google Scholar]
48. Schneider K, Harms K, Fendel H. The increased echogenicity of the pancreas in infants and children: the white pancreas. Eur J Pediatr. 1987;146:508–511. [PubMed] [Google Scholar]
49. Shawker TH, Linzer M, Hubbard VS. Chronic pancreatitis: the diagnostic significance of pancreatic size and echo amplitude. J Ultrasound Med. 1984;3:267–272. [PubMed] [Google Scholar]
50. Ustundag Y, Ceylan G, Hekimoglu K. Pancreatic hyperechogenicity on endoscopic ultrasound examination. World J Gastroenterol. 2011;17:2061–2062. [PMC free article] [PubMed] [Google Scholar]
51. Jeong HT, Lee MS, Kim MJ. Quantitative analysis of pancreatic echogenicity on transabdominal sonography: correlations with metabolic syndrome. J Clin Ultrasound. 2015;43:98–108. [PubMed] [Google Scholar]
52. Khan NA, Amin MS, Islam MZ. Pancreatic lipomatosis with massive steatorrhea. Mymensingh Med J. 2011;20:712–714. [PubMed] [Google Scholar]
53. Catanzaro R, Cuffari B, Italia A, Marotta F. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroenterol. 2016;22:7660–7675. [PMC free article] [PubMed] [Google Scholar]
54. Kim HJ, Byun JH, Park SH, Shin YM, Kim PN, Ha HK, Lee MG. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol. 2007;188:429–432. [PubMed] [Google Scholar]
55. Kim SY, Kim H, Cho JY, Lim S, Cha K, Lee KH, Kim YH, Kim JH, Yoon YS, Han HS, Kang HS. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology. 2014;271:104–112. [PubMed] [Google Scholar]
56. Katz DS, Hines J, Math KR, Nardi PM, Mindelzun RE, Lane MJ. Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am J Roentgenol. 1999;172:393–396. [PubMed] [Google Scholar]
57. Lim S, Bae JH, Chun EJ, Kim H, Kim SY, Kim KM, Choi SH, Park KS, Florez JC, Jang HC. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 2014;51:739–748. [PubMed] [Google Scholar]
58. Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, Butler PC. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933–942. [PMC free article] [PubMed] [Google Scholar]
59. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010;18:841–847. [PMC free article] [PubMed] [Google Scholar]
60. Gaborit B, Abdesselam I, Kober F, Jacquier A, Ronsin O, Emungania O, Lesavre N, Alessi MC, Martin JC, Bernard M, Dutour A. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes (Lond) 2015;39:480–487. [PubMed] [Google Scholar]
61. Hannukainen JC, Borra R, Linderborg K, Kallio H, Kiss J, Lepomäki V, Kalliokoski KK, Kujala UM, Kaprio J, Heinonen OJ, Komu M, Parkkola R, Ahotupa M, Lehtimäki T, Huupponen R, Iozzo P, Nuutila P. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol. 2011;54:545–552. [PubMed] [Google Scholar]
62. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Häring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–205. [PubMed] [Google Scholar]
63. Rebours V, Garteiser P, Ribeiro-Parenti L, Cavin JB, Doblas S, Pagé G, Bado A, Couvineau A, Ruszniewski P, Paradis V, Le Gall M, Van Beers BE, Couvelard A. Obesity-induced pancreatopathy in rats is reversible after bariatric surgery. Sci Rep. 2018;8:16295. [PMC free article] [PubMed] [Google Scholar]
64. Bray TJ, Chouhan MD, Punwani S, Bainbridge A, Hall-Craggs MA. Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology. Br J Radiol. 2018;91:20170344. [PMC free article] [PubMed] [Google Scholar]
65. Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–194. [PubMed] [Google Scholar]
66. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011;34:729–749. [PMC free article] [PubMed] [Google Scholar]
67. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med. 2008;60:1122–1134. [PMC free article] [PubMed] [Google Scholar]
68. Yokoo T, Shiehmorteza M, Hamilton G, Wolfson T, Schroeder ME, Middleton MS, Bydder M, Gamst AC, Kono Y, Kuo A, Patton HM, Horgan S, Lavine JE, Schwimmer JB, Sirlin CB. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology. 2011;258:749–759. [PMC free article] [PubMed] [Google Scholar]
69. Venkatesh SK, Xu S, Tai D, Yu H, Wee A. Correlation of MR elastography with morphometric quantification of liver fibrosis (Fibro-C-Index) in chronic hepatitis B. Magn Reson Med. 2014;72:1123–1129. [PubMed] [Google Scholar]
70. Popescu A, Săftoiu A. Can elastography replace fine needle aspiration? Endosc Ultrasound. 2014;3:109–117. [PMC free article] [PubMed] [Google Scholar]
71. Siddiqui N, Vendrami CL, Chatterjee A, Miller FH. Advanced MR Imaging Techniques for Pancreas Imaging. Magn Reson Imaging Clin N Am. 2018;26:323–344. [PubMed] [Google Scholar]
72. An H, Shi Y, Guo Q, Liu Y. Test-retest reliability of 3D EPI MR elastography of the pancreas. Clin Radiol. 2016;71:1068.e7–1068.e12. [PubMed] [Google Scholar]
73. Hirooka Y, Kuwahara T, Irisawa A, Itokawa F, Uchida H, Sasahira N, Kawada N, Itoh Y, Shiina T. JSUM ultrasound elastography practice guidelines: pancreas. J Med Ultrason (2001) 2015;42:151–174. [PubMed] [Google Scholar]
74. Goertz RS, Schuderer J, Strobel D, Pfeifer L, Neurath MF, Wildner D. Acoustic radiation force impulse shear wave elastography (ARFI) of acute and chronic pancreatitis and pancreatic tumor. Eur J Radiol. 2016;85:2211–2216. [PubMed] [Google Scholar]
75. Sakai NS, Taylor SA, Chouhan MD. Obesity, metabolic disease and the pancreas-Quantitative imaging of pancreatic fat. Br J Radiol. 2018;91:20180267. [PMC free article] [PubMed] [Google Scholar]
76. Dite P, Blaho M, Bojkova M, Jabandziev P, Kunovsky L. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. Dig Dis. 2020;38:143–149. [PubMed] [Google Scholar]
77. Elhady M, Elazab AAAM, Bahagat KA, Abdallah NA, Ibrahim GE. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity. J Pediatr Endocrinol Metab. 2019;32:19–26. [PubMed] [Google Scholar]
78. Romana BS, Chela H, Dailey FE, Nassir F, Tahan V. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? Endocr Metab Immune Disord Drug Targets. 2018;18:547–554. [PubMed] [Google Scholar]
79. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. J Clin Biochem Nutr. 2010;46:212–223. [PMC free article] [PubMed] [Google Scholar]
80. Kaya SD, Sinen O, Bülbül M. Gastric motor dysfunction coincides with the onset of obesity in rats fed with high-fat diet. Clin Exp Pharmacol Physiol. 2021;48:553–562. [PubMed] [Google Scholar]
81. Pavlov VA. The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response. Pharmacol Ther. 2021;222:107794. [PMC free article] [PubMed] [Google Scholar]
82. Chadda KR, Cheng TS, Ong KK. GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis. Obes Rev. 2021;22:e13177. [PubMed] [Google Scholar]
83. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart; Lung , and Blood Institute American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. [PubMed] [Google Scholar]
84. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–846. [PubMed] [Google Scholar]
85. Zhao ZZ, Xin LL, Xia JH, Yang SL, Chen YX, Li K. Long-term High-fat High-sucrose Diet Promotes Enlarged Islets and β-Cell Damage by Oxidative Stress in Bama Minipigs. Pancreas. 2015;44:888–895. [PubMed] [Google Scholar]
86. van Raalte DH, van der Zijl NJ, Diamant M. Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care. 2010;13:478–485. [PubMed] [Google Scholar]
87. Liu SN, Liu Q, Lei L, Sun SJ, Li CN, Huan Y, Hou SC, Shen ZF. The Chinese patent medicine, Jin-tang-ning, ameliorates hyperglycemia through improving β cell function in pre-diabetic KKAy mice. Chin J Nat Med. 2020;18:827–836. [PubMed] [Google Scholar]
88. Zhang X, Cui Y, Fang L, Li F. Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas. 2008;37:e31–e38. [PubMed] [Google Scholar]
89. Steven S, Hollingsworth KG, Small PK, Woodco*ck SA, Pucci A, Aribisala B, Al-Mrabeh A, Daly AK, Batterham RL, Taylor R. Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care. 2016;39:158–165. [PubMed] [Google Scholar]
90. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, Mari A, Heine RJ, Diamant M. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30:2916–2921. [PubMed] [Google Scholar]
91. Yamazaki H, Tsuboya T, Katanuma A, Kodama Y, Tauchi S, Dohke M, Maguchi H. Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study. Diabetes Care. 2016;39:1677–1683. [PubMed] [Google Scholar]
92. Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr Pract. 2001;7:44–51. [PubMed] [Google Scholar]
93. van der Zijl NJ, Goossens GH, Moors CC, van Raalte DH, Muskiet MH, Pouwels PJ, Blaak EE, Diamant M. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab. 2011;96:459–467. [PubMed] [Google Scholar]
94. Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Del Giglio M, Di Francesco V, Barillari M, Pozzi Mucelli R, Zamboni M. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring) 2011;19:1747–1754. [PubMed] [Google Scholar]
95. Lê KA, Ventura EE, Fisher JQ, Davis JN, Weigensberg MJ, Punyanitya M, Hu HH, Nayak KS, Goran MI. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34:485–490. [PMC free article] [PubMed] [Google Scholar]
96. Della Corte C, Mosca A, Majo F, Lucidi V, Panera N, Giglioni E, Monti L, Stronati L, Alisi A, Nobili V. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) 2015;83:656–662. [PubMed] [Google Scholar]
97. Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol. 2013;19:7930–7946. [PMC free article] [PubMed] [Google Scholar]
98. Dupont C, Sellier N, Chochillon C, Gobert JG, Helardot PG, Kalifa G. Pancreatic lipomatosis and duodenal stenosis or atresia in children. J Pediatr. 1989;115:603–605. [PubMed] [Google Scholar]
99. Patel S, Bellon EM, Haaga J, Park CH. Fat replacement of the exocrine pancreas. AJR Am J Roentgenol. 1980;135:843–845. [PubMed] [Google Scholar]
100. Lozano M, Navarro S, Pérez-Ayuso R, Llach J, Ayuso C, Guevara MC, Ros E. Lipomatosis of the pancreas: an unusual cause of massive steatorrhea. Pancreas. 1988;3:580–582. [PubMed] [Google Scholar]
101. Hellara O, Saad J, Ben Chaabene N, Ben Mansour W, Melki W, Loghmari H, Bdioui F, Safer L, Saffar H. [Diffuse primary fat replacement of the pancreas: an unusual cause of steatorrhea] Tunis Med. 2013;91:359–360. [PubMed] [Google Scholar]
102. Ambesh P, Lal H. Pancreatic Lipomatosis: Complete Replacement of Pancreas by Fat. J Clin Diagn Res. 2015;9:OL01. [PMC free article] [PubMed] [Google Scholar]
103. Tahtacı M, Algın O, Karakan T, Yürekli ÖT, Alışık M, Köseoğlu H, Metin MR, Bolat AD, Erel Ö, Ersoy O. Can pancreatic steatosis affect exocrine functions of pancreas? Turk J Gastroenterol. 2018;29:588–594. [PMC free article] [PubMed] [Google Scholar]
104. Midiri M, Lo Casto A, Sparacia G, D'Angelo P, Malizia R, Finazzo M, Montalto G, Solbiati L, Lagalla R, De Maria M. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. AJR Am J Roentgenol. 1999;173:187–192. [PubMed] [Google Scholar]
105. So CB, Cooperberg PL, Gibney RG, Bogoch A. Sonographic findings in pancreatic lipomatosis. AJR Am J Roentgenol. 1987;149:67–68. [PubMed] [Google Scholar]
106. Melitas C, Meiselman M. Metabolic Pancreatitis: Pancreatic Steatosis, Hypertriglyceridemia, and Associated Chronic Pancreatitis in 3 Patients with Metabolic Syndrome. Case Rep Gastroenterol. 2018;12:331–336. [PMC free article] [PubMed] [Google Scholar]
107. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes. 2001;50:1771–1777. [PubMed] [Google Scholar]
108. Martínez J, Sánchez-Payá J, Palazón JM, Suazo-Barahona J, Robles-Díaz G, Pérez-Mateo M. Is obesity a risk factor in acute pancreatitis? Pancreatology. 2004;4:42–48. [PubMed] [Google Scholar]
109. Martínez J, Johnson CD, Sánchez-Payá J, de Madaria E, Robles-Díaz G, Pérez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206–209. [PubMed] [Google Scholar]
110. Acharya C, Navina S, Singh VP. Role of pancreatic fat in the outcomes of pancreatitis. Pancreatology. 2014;14:403–408. [PMC free article] [PubMed] [Google Scholar]
111. Zyromski NJ, Mathur A, Pitt HA, Lu D, Gripe JT, Walker JJ, Yancey K, Wade TE, Swartz-Basile DA. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G552–G558. [PubMed] [Google Scholar]
112. Lankisch PG, Schirren CA. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas. 1990;5:626–629. [PubMed] [Google Scholar]
113. Suazo-Baráhona J, Carmona-Sánchez R, Robles-Díaz G, Milke-García P, Vargas-Vorácková F, Uscanga-Domínguez L, Peláez-Luna M. Obesity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am J Gastroenterol. 1998;93:1324–1328. [PubMed] [Google Scholar]
114. Blomgren KB, Sundström A, Steineck G, Wiholm BE. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care. 2002;25:298–302. [PubMed] [Google Scholar]
115. Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg. 1993;80:484–486. [PubMed] [Google Scholar]
116. Frossard JL, Lescuyer P, Pastor CM. Experimental evidence of obesity as a risk factor for severe acute pancreatitis. World J Gastroenterol. 2009;15:5260–5265. [PMC free article] [PubMed] [Google Scholar]
117. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355–365. [PubMed] [Google Scholar]
118. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–2180. [PubMed] [Google Scholar]
119. de Oliveira C, Khatua B, Noel P, Kostenko S, Bag A, Balakrishnan B, Patel KS, Guerra AA, Martinez MN, Trivedi S, McCullough A, Lam-Himlin DM, Navina S, Faigel DO, f*ckami N, Pannala R, Phillips AE, Papachristou GI, Kershaw EE, Lowe ME, Singh VP. Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation. J Clin Invest. 2020;130:1931–1947. [PMC free article] [PubMed] [Google Scholar]
120. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, Pitt HA. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007;9:312–318. [PMC free article] [PubMed] [Google Scholar]
121. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9:92–97. [PMC free article] [PubMed] [Google Scholar]
122. Yang DM, Kim HC, Ryu JK, Joo KR, Ahn KJ. Sonographic appearance of focal fatty infiltration of the pancreas. J Clin Ultrasound. 2010;38:45–47. [PubMed] [Google Scholar]
123. Gaujoux S, Cortes A, Couvelard A, Noullet S, Clavel L, Rebours V, Lévy P, Sauvanet A, Ruszniewski P, Belghiti J. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15–23. [PubMed] [Google Scholar]
124. Lee SE, Jang JY, Lim CS, Kang MJ, Kim SH, Kim MA, Kim SW. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann Surg. 2010;251:932–936. [PubMed] [Google Scholar]
125. Tranchart H, Gaujoux S, Rebours V, Vullierme MP, Dokmak S, Levy P, Couvelard A, Belghiti J, Sauvanet A. Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg. 2012;256:139–145. [PubMed] [Google Scholar]
126. Søreide K, Labori KJ. Risk factors and preventive strategies for post-operative pancreatic fistula after pancreatic surgery: a comprehensive review. Scand J Gastroenterol. 2016;51:1147–1154. [PMC free article] [PubMed] [Google Scholar]
127. Honka H, Koffert J, Hannukainen JC, Tuulari JJ, Karlsson HK, Immonen H, Oikonen V, Tolvanen T, Soinio M, Salminen P, Kudomi N, Mari A, Iozzo P, Nuutila P. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J Clin Endocrinol Metab. 2015;100:2015–2023. [PubMed] [Google Scholar]
128. Karasu S, Gungor F, Onak C, Dilek ON. Relation of computed tomography features of the pancreatic tissue and development of pancreatic fistula after pancreaticoduodenectomy. Clin Imaging. 2021;72:114–119. [PubMed] [Google Scholar]
129. Guo XJ, Zhu F, Yang MW, Jiang JX, He Z, Gao J, Huang T, Zhao R, Zhang LD, Wang M, Qin RY FACS. A score model based on pancreatic steatosis and fibrosis and pancreatic duct diameter to predict postoperative pancreatic fistula after Pancreatoduodenectomy. BMC Surg. 2019;19:75. [PMC free article] [PubMed] [Google Scholar]
130. Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, Ng K, Chong C, Zheng ZJ, Wong MCS. Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology. 2021;160:744–754. [PubMed] [Google Scholar]
131. Téoule P, Rasbach E, Oweira H, Otto M, Rahbari NN, Reissfelder C, Rückert F, Birgin E. Obesity and Pancreatic Cancer: A Matched-Pair Survival Analysis. J Clin Med. 2020;9 [PMC free article] [PubMed] [Google Scholar]
132. Chung HS, Lee JS, Song E, Kim JA, Roh E, Yu JH, Kim NH, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi KM. Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: A Nationwide Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. 2021;30:521–528. [PubMed] [Google Scholar]
133. Lang J, Kunovský L, Kala Z, Trna J. Risk factors of pancreatic cancer and their possible uses in diagnostics. Neoplasma. 2021;68:227–239. [PubMed] [Google Scholar]
134. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:459–466. [PubMed] [Google Scholar]
135. Lesmana CRA, Gani RA, Lesmana LA. Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience. JGH Open. 2018;2:4–7. [PMC free article] [PubMed] [Google Scholar]
136. Hori M, Takahashi M, Hiraoka N, Yamaji T, Mutoh M, Ishigamori R, Furuta K, Okusaka T, Shimada K, Kosuge T, Kanai Y, Nakagama H. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 2014;5:e53. [PMC free article] [PubMed] [Google Scholar]
137. Rebours V, Gaujoux S, d'Assignies G, Sauvanet A, Ruszniewski P, Lévy P, Paradis V, Bedossa P, Couvelard A. Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN) Clin Cancer Res. 2015;21:3522–3528. [PubMed] [Google Scholar]
138. Mathur A, Hernandez J, Shaheen F, Shroff M, Dahal S, Morton C, Farrior T, Kedar R, Rosemurgy A. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. HPB (Oxford) 2011;13:404–410. [PMC free article] [PubMed] [Google Scholar]
139. Prachayakul V, Aswakul P. Pancreatic Steatosis: What Should Gastroenterologists Know? JOP. 2015;16:227–231. [Google Scholar]
140. Mathur A, Zyromski NJ, Pitt HA, Al-Azzawi H, Walker JJ, Saxena R, Lillemoe KD. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208:989–94; discussion 994. [PubMed] [Google Scholar]
141. Annett S, Moore G, Robson T. Obesity and Cancer Metastasis: Molecular and Translational Perspectives. Cancers (Basel) 2020;12 [PMC free article] [PubMed] [Google Scholar]
142. Lammert E, Cleaver O, Melton D. Role of endothelial cells in early pancreas and liver development. Mech Dev. 2003;120:59–64. [PubMed] [Google Scholar]
143. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–1351. [PMC free article] [PubMed] [Google Scholar]
144. Yamazaki H, Tauchi S, Kimachi M, Dohke M, Hanawa N, Kodama Y, Katanuma A, Yamamoto Y, f*ckuma S, f*ckuhara S. Association between pancreatic fat and incidence of metabolic syndrome: a 5-year Japanese cohort study. J Gastroenterol Hepatol. 2018;33:2048–2054. [PubMed] [Google Scholar]
145. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. [PubMed] [Google Scholar]
146. Zhou J, Li ML, Zhang DD, Lin HY, Dai XH, Sun XL, Li JT, Song LY, Peng H, Wen MM. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016;16:578–583. [PubMed] [Google Scholar]
147. Dreiling DA, Elsbach P, Schaffner F, Schwartz IL. The effect of restriction of protein and total calories on pancreatic function in obese patients. Gastroenterology. 1962;42:686–690. [PubMed] [Google Scholar]
148. Jia DM, f*ckumitsu KI, Tabaru A, Akiyama T, Otsuki M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1332–R1340. [PubMed] [Google Scholar]
149. Patel K, Trivedi RN, Durgampudi C, Noel P, Cline RA, DeLany JP, Navina S, Singh VP. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation. Am J Pathol. 2015;185:808–819. [PMC free article] [PubMed] [Google Scholar]
150. Zsóri G, Illés D, Ivány E, Kosár K, Holzinger G, Tajti M, Pálinkás E, Szabovik G, Nagy A, Palkó A, Czakó L. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium. Metab Syndr Relat Disord. 2019;17:289–295. [PubMed] [Google Scholar]
151. Fang T, Huang S, Chen Y, Chen Z, Chen J, Hu W. Glucagon Like Peptide-1 Receptor Agonists Alters Pancreatic and Hepatic Histology and Regulation of Endoplasmic Reticulum Stress in High-fat Diet Mouse Model. Exp Clin Endocrinol Diabetes. 2020 [PubMed] [Google Scholar]
152. Souza-Mello V, Gregório BM, Relvas-Lucas B, da Silva Faria T, Aguila MB, Mandarim-de-Lacerda CA. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice. Pancreas. 2011;40:715–722. [PubMed] [Google Scholar]
153. Zhao L, Jiang SJ, Lu FE, Xu LJ, Zou X, Wang KF, Dong H. Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic β cells. Chin J Integr Med. 2016;22:496–502. [PubMed] [Google Scholar]
